Physician profile
Cameron Todd
NPI 1972065548
$3,968.68
in general payments reported to CMS, 2019-2025
12 companies · $3,323 in 2025
The $3,323 reported for 2025 was more than what 94% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $34.31 · 2024: $612 · 2025: $3,323.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,850 · Consulting Fee: $1,800 · Travel and Lodging: $319.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,849.50 |
| Consulting Fee | $1,800.00 |
| Travel and Lodging | $319.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cochlear Americas | $2,456.83 | 2024-2025 | Baha, Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode, Osia Osi300 Implant |
| Inspire Medical Systems, INC. | $487.25 | 2024-2025 | Inspire |
| Glaxosmithkline, LLC. | $308.40 | 2025 | Nucala |
| Preceptis Medical, INC. | $196.40 | 2025 | |
| Astrazeneca Pharmaceuticals Lp | $136.09 | 2024-2025 | Tezspire |
| Medtronic, INC. | $114.53 | 2024 | Ligasure, Pteye Parathyroid Detection System |
| Advanced Bionics, LLC | $106.10 | 2025 | Hires Ultra Ci Hifocus Ms Electrode |
| Stryker Corporation | $70.32 | 2023-2024 | Vsp System, Vsp Cranial, Na, Delta |
| Neurent Medical Limited | $29.92 | 2025 | Neuromark Radiofrequency Console, Neuromark System |
| Smith+Nephew, INC. | $25.83 | 2024 | Halo |
| Optinose US, INC. | $21.16 | 2025 | |
| Itamar Medical INC | $15.85 | 2025 | Watchpatone |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cameron Todd listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.